Float Short %

1.91

Margin Of Safety %

Put/Call OI Ratio

0.3

EPS Next Q Diff

EPS Last/This Y

4.22

EPS This/Next Y

0.37

Price

14.92

Target Price

Analyst Recom

Performance Q

-1.97

Relative Volume

1.51

Beta

0.72

Ticker: AMRN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	AMRN	15.89	0.32	0.00	8694
2025-11-11	AMRN	16.16	0.32	0.00	8815
2025-11-12	AMRN	16.19	0.31	0.00	8948
2025-11-13	AMRN	16.33	0.31	0.24	9023
2025-11-14	AMRN	16.32	0.30	0.03	9192
2025-11-17	AMRN	16.11	0.30	2.50	9204
2025-11-18	AMRN	16.74	0.31	0.87	9239
2025-11-19	AMRN	16.97	0.32	0.17	9531
2025-11-20	AMRN	16.39	0.32	0.05	9663
2025-11-21	AMRN	16.37	0.31	2.57	9858
2025-11-24	AMRN	15.88	0.35	0.11	7144
2025-11-25	AMRN	15.7	0.35	0.27	7311
2025-11-26	AMRN	16.18	0.35	0.04	7370
2025-12-01	AMRN	15.62	0.32	0.11	7907
2025-12-02	AMRN	15.62	0.32	0.10	7926
2025-12-03	AMRN	16.29	0.32	0.04	7967
2025-12-04	AMRN	16.53	0.31	0.12	8191
2025-12-05	AMRN	16.5	0.31	0.00	8210
2025-12-08	AMRN	14.94	0.30	0.36	8361
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	AMRN	15.85	117.5	-	0.22
2025-11-11	AMRN	16.09	117.5	-	0.22
2025-11-12	AMRN	16.13	117.5	-	0.22
2025-11-13	AMRN	16.25	117.5	-	0.22
2025-11-14	AMRN	16.33	117.5	-	0.22
2025-11-17	AMRN	16.05	117.5	-	0.22
2025-11-18	AMRN	16.75	117.5	-	0.22
2025-11-19	AMRN	16.98	117.5	-	0.22
2025-11-20	AMRN	16.42	117.5	-	0.22
2025-11-21	AMRN	16.34	117.5	-	0.22
2025-11-24	AMRN	15.88	117.5	-	0.22
2025-11-25	AMRN	15.72	117.5	-	0.22
2025-11-26	AMRN	16.09	117.5	-	0.22
2025-12-01	AMRN	15.59	117.5	-	0.22
2025-12-02	AMRN	15.53	117.5	-	0.22
2025-12-03	AMRN	16.29	117.5	-	0.22
2025-12-04	AMRN	16.48	117.5	-	0.22
2025-12-05	AMRN	16.54	117.5	-	0.22
2025-12-08	AMRN	14.92	117.5	-	0.22
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	AMRN	0.00	0.64	1.65
2025-11-11	AMRN	0.00	0.64	1.65
2025-11-12	AMRN	0.00	0.64	1.79
2025-11-13	AMRN	0.00	0.64	1.79
2025-11-14	AMRN	0.00	0.64	1.79
2025-11-17	AMRN	0.00	1.47	1.79
2025-11-18	AMRN	0.00	1.47	1.79
2025-11-19	AMRN	0.00	1.47	1.79
2025-11-20	AMRN	0.00	1.47	1.79
2025-11-21	AMRN	0.00	1.47	1.79
2025-11-24	AMRN	0.00	3.16	1.79
2025-11-25	AMRN	0.00	3.16	1.79
2025-11-26	AMRN	0.00	3.16	1.91
2025-12-01	AMRN	0.00	3.15	1.91
2025-12-02	AMRN	0.00	3.15	1.91
2025-12-03	AMRN	0.00	3.15	1.91
2025-12-04	AMRN	0.00	3.15	1.91
2025-12-05	AMRN	0.00	3.15	1.91
2025-12-08	AMRN	0.00	3.15	1.91
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.07

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

3.15

Beta

0.72

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.9

Max Drawdown 5-Year %

-95.5

Target Price

P/E

Forward P/E

104.27

PEG

P/S

1.37

P/B

0.68

P/Free Cash Flow

EPS

-4.17

Average EPS Est. Cur. Y

0.22

EPS Next Y. (Est.)

0.59

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-37.87

Relative Volume

1.51

Return on Equity vs Sector %

-45.7

Return on Equity vs Industry %

-55.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 275

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y